[ Price : $8.95]
FDA investigates another death of a young boy who received Sarepta Therapeutics gene therapy Elevidys for Duchenne muscular dystro...[ Price : $8.95]
Roche announces new data on its Alzheimers therapy trontinemab and its plans to begin two Phase 3 clinical trials by the end of th...[ Price : $8.95]
Bipartisan House lawmakers urge FDA to block counterfeit anti-obesity medications entering the U.S.[ Price : $8.95]
FDA reverses its enforcement stance against Sarepta Therapeutics and Duchenne Muscular Dystrophy gene therapy Elevidys after deter...[ Price : $8.95]
FDA clears a Stereotaxis 510(k) for its MAGiC Sweep catheter, a robotically navigated high-density electrophysiology mapping cathe...[ Price : $8.95]
FDA commissioner Marty Makary defends CBER director Vinay Prasad from recent criticism by Trump confidant Laura Loomer.[ Price : $8.95]
FDA extends by three months its review of a Bayer NDA for elinzanetant, a neurokinin 1 and neurokinin 3 receptor antagonist for tr...[ Price : $8.95]
FDA and American Society of Clinical Oncology researchers urge drug makers to abandon outdated drug dosing strategies that are pot...